The UK Health Security Agency (UKHSA) has published its latest quarterly epidemiological commentary on mandatory surveillance data for healthcare associated infections (HCAI), covering the three-month window running from April to June 2026. The release carries accredited official statistics status.
Infections Under Surveillance
The report draws on mandatory reporting across several categories of infection. These include MRSA (meticillin-resistant Staphylococcus aureus) and MSSA (meticillin-sensitive Staphylococcus aureus), both of which are tracked as indicators of infection control performance within healthcare environments.
Gram-negative bacteraemia — bloodstream infections caused by a class of bacteria that are increasingly associated with antimicrobial resistance — also features prominently in the surveillance framework. The specific organisms monitored within this category include Escherichia coli (E. coli), Pseudomonas aeruginosa, and Klebsiella species.
Additionally, the commentary addresses Clostridioides difficile (C. difficile) infection, a pathogen commonly linked to antibiotic use and a persistent concern in inpatient healthcare settings.
Scope and Classification
According to the UKHSA release, the commentary analyses trends across healthcare settings using data submitted through mandatory national reporting channels. The classification as accredited official statistics reflects adherence to the Code of Practice for Statistics set by the UK Statistics Authority.
Why Mandatory Surveillance Matters
Mandatory HCAI surveillance serves as a core mechanism for monitoring infection rates at both trust and national level. By requiring healthcare providers to report cases of specified pathogens, the system generates a standardised evidence base that informs infection prevention policy and resource allocation.
Gram-negative bacteraemias in particular have attracted growing attention in recent years, given their association with resistance to multiple antibiotic classes. Tracking organisms such as E. coli and Klebsiella species at a population level allows public health bodies to identify shifts in incidence that may signal emerging resistance patterns or lapses in clinical hygiene practice.
C. difficile, meanwhile, remains a marker of broader antimicrobial stewardship, since infection rates tend to reflect prescribing habits as much as direct transmission within wards.
Publication Cycle
The UKHSA issues this commentary on a quarterly basis, meaning the April-to-June 2026 figures represent the second quarter of the current reporting year. Each release is intended to provide a timely, comparable snapshot of HCAI trends, enabling year-on-year and quarter-on-quarter analysis by researchers, commissioners, and infection control teams.
Full data tables and methodology notes accompany the published commentary, as is standard for accredited official statistics releases.